Skip to main content

Advertisement

SpringerLink
Log in

Similarities and Differences Between Migraine in Children and Adults: Presentation, Disability, and Response to Treatment

  • Psychological and Behavioral Aspects of Headache and Pain (D Buse, Section Editor)
  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

This review presents findings from investigations of migraine in children and adults. Similarities and differences in the presentation, related consequences, and treatments between children and adults are reviewed.

Recent Findings

Significant similarities exist in the presentation, disability, and treatments for migraine between children and adults. Despite such similarities, many adult migraine treatments adapted for use in children are not rigorously tested prior to becoming a part of routine care in youth. Existing research suggests that not all approaches are equally effective across age groups. Specifically, psychological treatments are shown to be somewhat less effective in adults than in children. Pharmacological interventions found to be statistically significant relative to placebo in adults may not be as effective in children and have the potential to present more risk than benefit when used in youth. The placebo effect in both children and adults is robust and is need of further study. Better understanding of treatment mechanisms for all interventions across the age spectrum is needed.

Summary

Although migraine treatments determined to be effective for adults are frequently adapted for use in children with little evaluation prior to implementation, existing research suggests that this approach may not be the best practice. Adaptation of adult pharmacological treatment for use in youth may present a particular risk in comparison to benefits gained. Because of the known efficacy of psychological treatments, such as cognitive behavioral therapy, more universal use of these interventions should be considered, either as first-line treatment or in combination with pill-based therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68(5):343–9.

    Article  CAS  PubMed  Google Scholar 

  2. Stewart WF, Ricci JA, Chee E, Morganstein D, Lipton R. Lost productive time and cost due to common pain conditions in the US workforce. JAMA. 2003;290(18):2443–54.

    Article  CAS  PubMed  Google Scholar 

  3. Hershey AD, Powers SW, Winner P, Kabbouche M. Pediatric headaches in clinical practice. West Sussex: UK John Wiley & Sons, Ltd.; 2009.

    Book  Google Scholar 

  4. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267(1):64–9.

    Article  CAS  PubMed  Google Scholar 

  5. Split W, Neuman W. Epidemiology of migraine among students from randomly selected secondary schools in Lodz. Headache. 1999;39(7):494–501.

    Article  CAS  PubMed  Google Scholar 

  6. Headache Classification C, Olesen J, Bousser MG, Diener HC, Dodick D, First M, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;26(6):742–6.

    Article  Google Scholar 

  7. Goadsby PJ, Lipton RB, Ferrari MD. Migraine—current understanding and treatment. N Engl J Med. 2002;346(4):257–70.

    Article  CAS  PubMed  Google Scholar 

  8. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain. 2013;14:1.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163–96.

    Article  PubMed  Google Scholar 

  10. Gorodzinsky AY, Hainsworth KR, Weisman SJ. School functioning and chronic pain: a review of methods and measures. J Pediatr Psychol. 2011;36(9):991–1002.

    Article  PubMed  Google Scholar 

  11. • Buse DC, Manack AN, Fanning KM, Serrano D, Reed ML, Turkel CC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: results from the American Migraine Prevalence and Prevention Study. Headache. 2012;52(10):1456–70. Review of chronic migraine prevalence, costs, and disability.

    Article  PubMed  Google Scholar 

  12. • Sekhar M, Sonal EA. Migraine management: how do the adult and paediatric migraines differ? Saudi Pharmaceutical Journal. 2012;20(1):1–7. Review of differences in adult and pediatric migraine.

    Article  Google Scholar 

  13. •• Holroyd KA, Drew JB. Behavioral approaches to the treatment of migraine. Semin Neurol. 2006;26(2):199–207. Review of effectiveness of CBT and medication for adult migraine.

    Article  PubMed  Google Scholar 

  14. Buse DC, Scher AI, Dodick DW, Reed ML, Fanning KM, Manack Adams A, et al. Impact of migraine on the family: perspectives of people with migraine and their spouse/domestic partner in the CaMEO study. Mayo Clin Proc. 2016;91(5):596–611.

    Article  Google Scholar 

  15. Smith R. Impact of migraine on the family. Headache. 1998;38(6):423–6.

    Article  CAS  PubMed  Google Scholar 

  16. Eccleston C, Crombez G, Scotford A, Clinch J, Connell H. Adolescent chronic pain: patterns and predictors of emotional distress in adolescents with chronic pain and their parents. Pain. 2004;108(3):221–9.

    Article  PubMed  Google Scholar 

  17. Lipton RB, Bigal ME, Kolodner K, Stewart WF, Liberman JN, Steiner TJ. The family impact of migraine: population-based studies in the USA and UK. Cephalalgia. 2003;23(6):429–40.

    Article  CAS  PubMed  Google Scholar 

  18. Holmes AM, Deb P. The effect of chronic illness on the psychological health of family members. J Ment Health Policy Econ. 2003;6(1):13–22.

    PubMed  Google Scholar 

  19. Lieberman MA, Fisher L. The impact of chronic illness on the health and well-being of family members. Gerontologist. 1995;35(1):94–102.

    Article  CAS  PubMed  Google Scholar 

  20. Palermo TM, Valrie CR, Karlson CW. Family and parent influences on pediatric chronic pain: a developmental perspective. Am Psychol. 2014;69(2):142–52.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Lewandowski AS, Palermo TM, Stinson J, Handley S, Chambers CT. Systematic review of family functioning in families of children and adolescents with chronic pain. J Pain. 2010;11(11):1027–38.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Campo JV, Bridge J, Lucas A, Savorelli S, Walker L, Di Lorenzo C, et al. Physical and emotional health of mothers of youth with functional abdominal pain. Arch Pediatr Adolesc Med. 2007;161(2):131–7.

    Article  PubMed  Google Scholar 

  23. Daniels D, Moos RH, Billings AG, Miller JJ III. Psychosocial risk and resistance factors among children with chronic illness, healthy siblings, and healthy controls. J Abnorm Child Psychol. 1987;15(2):295–308.

    Article  CAS  PubMed  Google Scholar 

  24. •• Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, Korbee LL, Porter LL, Hershey AD, CHAMP Investigators. Trial of amitriptyline, topiramate, and placebo for pediatric migraine. N Engl J Med. 2017;376(2):115–124. Results from the CHAMP study that indicate preventative medications may present more risk than benefit in children.

  25. Food and Drug Administration. Guidance for industry migraine: developing drugs for acute treatment. 2014. https://www.fda.gov/downloads/drugs/guidances/ucm419465.pdf

  26. • Hershey AD. Current approaches to the diagnosis and management of paediatric migraine. Lancet Neurol. 2010;9(2):190–204. Review of presentation and treatment of pediatric migraine.

    Article  CAS  PubMed  Google Scholar 

  27. Linder SL, Mathew NT, Cady RK, Finlayson G, Ishkanian G, Lewis DW. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial. Headache. 2008;48(9):1326–36.

    Article  PubMed  Google Scholar 

  28. Ahonen K, Hamalainen ML, Eerola M, Hoppu K. A randomized trial of rizatriptan in migraine attacks in children. Neurology. 2006;67(7):1135–40.

    Article  CAS  PubMed  Google Scholar 

  29. Brandes JL, Kudrow D, Stark SR, O'Carroll CP, Adelman JU, O'Donnell FJ, et al. Sumatriptan-naproxen for acute treatment of migraine: a randomized trial. JAMA. 2007;297(13):1443–54.

    Article  CAS  PubMed  Google Scholar 

  30. Smith TR, Sunshine A, Stark SR, Littlefield DE, Spruill SE, Alexander WJ. Sumatriptan and naproxen sodium for the acute treatment of migraine. Headache. 2005;45(8):983–91.

    Article  PubMed  Google Scholar 

  31. Dodick DW, Turkel CC, DeGryse RE, Aurora SK, Silberstein SD, Lipton RB, et al. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 2010;50(6):921–36.

    Article  PubMed  Google Scholar 

  32. Sun H, Dodick DW, Silberstein S, Goadsby PJ, Reuter U, Ashina M, et al. Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15(4):382–90.

    Article  CAS  PubMed  Google Scholar 

  33. Dodick DW, Turkel CC, DeGryse RE, Diener HC, Lipton RB, Aurora SK, et al. Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example. J Pain. 2015;16(2):164–75.

    Article  PubMed  Google Scholar 

  34. Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache. 2000;40(7):539–49.

    Article  CAS  PubMed  Google Scholar 

  35. Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand. 1974;50(1):109–15.

    Article  CAS  PubMed  Google Scholar 

  36. Levinstein B. A comparative study of cyproheptadine, amitriptyline, and propranolol in the treatment of adolescent migraine. Cephalalgia. 1991;11:122–3.

    Article  Google Scholar 

  37. Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache. 2005;45(10):1304–12.

    Article  PubMed  Google Scholar 

  38. Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, et al. Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study. Headache. 2008;48(7):1012–25.

    Article  PubMed  Google Scholar 

  39. Powers SW, Hershey AD, Coffey CS, Group CS. The Childhood and Adolescent Migraine Prevention (CHAMP) Study: “What Do We Do Now?”. Headache. 2017;57(2):180–3.

    Article  PubMed  Google Scholar 

  40. Kroner JW, Hershey AD, Kashikar-Zuck SM, SL LC, Allen JR, Slater SK, et al. Cognitive behavioral therapy plus amitriptyline for children and adolescents with chronic migraine reduces headache days to </=4 per month. Headache. 2016;56:711–6.

    Article  PubMed  Google Scholar 

  41. Jackson JL. Pediatric migraine headache—still searching for effective treatments. N Engl J Med. 2017;376(2):169–70.

    Article  PubMed  Google Scholar 

  42. Faria V, Kossowsky J, Petkov MP, Kaptchuk TJ, Kirsch I, Lebel A, et al. Parental attitudes about placebo use in children. J Pediatr. 2017;181:272–8 e10.

    Article  PubMed  Google Scholar 

  43. Faria V, Linnman C, Lebel A, Borsook D. Harnessing the placebo effect in pediatric migraine clinic. J Pediatr. 2014;165(4):659–65.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Powers SW, Andrasik F. Biobehavioral treatment, disability, and psychological effects of pediatric headache. Pediatr Ann. 2005;34(6):461–5.

    Article  PubMed  Google Scholar 

  45. Eccleston C, Palermo TM, Williams AC, Lewandowski Holley A, Morley S, Fisher E, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2014;5:CD003968.

    Google Scholar 

  46. •• Powers SW, Kashikar-Zuck SM, Allen JR, LeCates SL, Slater SK, Zafar M, et al. Cognitive behavioral therapy plus amitriptyline for chronic migraine in children and adolescents: a randomized clinical trial. JAMA. 2013;310(24):2622–30. Results of an RCT demonstrating effectiveness of CBT for migraine management in children.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Ernst MM, O'Brien HL, Powers SW. Cognitive-behavioral therapy: how medical providers can increase patient and family openness and access to evidence-based multimodal therapy for pediatric migraine. Headache. 2015;55(10):1382–96.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Eccleston C, Palermo TM, WA C, Lewandowski A, Morley S, Fisher E, et al. Psychological therapies for the management of chronic and recurrent pain in children and adolescents. Cochrane Database Syst Rev. 2012;12:CD003968.

    PubMed  PubMed Central  Google Scholar 

  49. Holroyd KA. Management of migraine and tension-type headaches. In: Trafton J, editor. Best practices in the behavioral management of chronic disease: neuropsychiatric disorders, vol. 1. Los Altos: Institute for Disease Management; 2003.

    Google Scholar 

  50. Smitherman TA, Wells RE, Ford SG. Emerging behavioral treatments for migraine. Curr Pain Headache Rep. 2015;19(4):13.

    Article  PubMed  Google Scholar 

  51. Smith SM, Dworkin RH, Turk DC, Baron R, Polydefkis M, Tracey I, et al. The potential role of sensory testing, skin biopsy, and functional brain imaging as biomarkers in chronic pain clinical trials: IMMPACT considerations. J Pain. 2017;18(7):757–77.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Youssef AM, Ludwick A, Wilcox SL, Lebel A, Peng K, Colon E, et al. In child and adult migraineurs the somatosensory cortex stands out... again: an arterial spin labeling investigation. Hum Brain Mapp. 2017;38(8):4078–87.

    Article  PubMed  Google Scholar 

  53. Hubbard CS, Becerra L, Smith JH, DeLange JM, Smith RM, Black DF, et al. Brain changes in responders vs. non-responders in chronic migraine: markers of disease reversal. Front Hum Neurosci. 2016;10:497.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Simons LE, Pielech M, Erpelding N, Linnman C, Moulton E, Sava S, et al. The responsive amygdala: treatment-induced alterations in functional connectivity in pediatric complex regional pain syndrome. Pain. 2014;155(9):1727–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Becerra L, Sava S, Simons LE, Drosos AM, Sethna N, Berde C, et al. Intrinsic brain networks normalize with treatment in pediatric complex regional pain syndrome. Neuroimage Clin. 2014;6:347–69.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Behavioral Medicine and Clinical Psychology, Cincinnati Children’s Hospital Medical Center, 7039, 3333 Burnet Avenue, Cincinnati, OH, 45229-3039, USA

    Ashley M. Kroon Van Diest, Michelle M. Ernst, Shalonda Slater & Scott W. Powers

  2. Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA

    Michelle M. Ernst, Shalonda Slater & Scott W. Powers

  3. Headache Center, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, USA

    Shalonda Slater & Scott W. Powers

Authors
  1. Ashley M. Kroon Van Diest
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michelle M. Ernst
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shalonda Slater
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Scott W. Powers
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Scott W. Powers.

Ethics declarations

Conflict of Interest

The authors have nothing to disclose.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Psychological and Behavioral Aspects of Headache and Pain

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kroon Van Diest, A.M., Ernst, M.M., Slater, S. et al. Similarities and Differences Between Migraine in Children and Adults: Presentation, Disability, and Response to Treatment. Curr Pain Headache Rep 21, 48 (2017). https://doi.org/10.1007/s11916-017-0648-2

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-017-0648-2

Keywords

Search

Navigation